Page last updated: 2024-11-03

rabeprazole and Depression

rabeprazole has been researched along with Depression in 2 studies

Rabeprazole: A 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.

Depression: Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Takeuchi, T1
Oota, K1
Harada, S1
Edogawa, S1
Kojima, Y1
Sanomura, M1
Sakaguchi, M1
Hayashi, K1
Hongoh, Y1
Itabashi, T1
Kitae, H1
Hoshimoto, M1
Takeuchi, N1
Higuchi, K1
Beyenburg, S1
Schönegger, K1

Trials

1 trial available for rabeprazole and Depression

ArticleYear
Characteristics of refractory gastroesophageal reflux disease (GERD) symptoms -is switching proton pump inhibitors based on the patient's CYP2C19 genotype an effective management strategy?
    Internal medicine (Tokyo, Japan), 2015, Volume: 54, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Alcohol Drinking; Anxiety; Cytochrome P-450 CYP2C19; Depression; Dos

2015

Other Studies

1 other study available for rabeprazole and Depression

ArticleYear
Severe bradycardia in a stroke patient caused by a single low dose of escitalopram.
    European neurology, 2007, Volume: 57, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Antidepressive Agents, Second-Generation

2007